Literature DB >> 31191156

Transverse myelitis associated with yellow fever vaccination.

Kyle D Bartol1, Jose L Aguirre1, Salvatore V Labruzzo2, Russ P Henriet3.   

Abstract

Yellow fever is a mosquito-borne viral hemorrhagic fever endemic to sub-Saharan Africa and South America associated with significant morbidity and mortality. The use of a live attenuated vaccine can prevent yellow fever, but vaccine-associated neurologic disease has been reported and is a safety concern. We present the case of a previously healthy 35-year-old active-duty man who received the yellow fever vaccine prior to deployment and subsequently developed progressive neurologic dysfunction consistent with transverse myelitis.

Entities:  

Keywords:  Transverse myelitis; yellow fever; yellow fever vaccine–associated neurologic disease

Year:  2019        PMID: 31191156      PMCID: PMC6541067          DOI: 10.1080/08998280.2019.1573405

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  7 in total

1.  Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil.

Authors:  Reinaldo de Menezes Martins; Ana Luiza Braz Pavão; Patrícia Mouta Nunes de Oliveira; Paulo Roberto Gomes dos Santos; Sandra Maria D Carvalho; Renate Mohrdieck; Alexandre Ribeiro Fernandes; Helena Keico Sato; Patricia Mandali de Figueiredo; Vanessa Dos Reis von Doellinger; Maria da Luz Fernandes Leal; Akira Homma; Maria de Lourdes S Maia
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641

2.  Vaccination Challenges in Confronting the Resurgent Threat From Yellow Fever.

Authors:  Lin H Chen; Davidson H Hamer
Journal:  JAMA       Date:  2017-11-07       Impact factor: 56.272

3.  Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases.

Authors:  Ann W McMahon; Rachel B Eidex; Anthony A Marfin; Michelle Russell; James J Sejvar; Lewis Markoff; Edward B Hayes; Robert T Chen; Robert Ball; M Miles Braun; Martin Cetron
Journal:  Vaccine       Date:  2006-11-27       Impact factor: 3.641

4.  Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002.

Authors:  Martin S Cetron; Anthony A Marfin; Kathleen G Julian; Duane J Gubler; Donald J Sharp; Rachel S Barwick; Leisa H Weld; Robert Chen; Richard D Clover; Jaime Deseda-Tous; Victor Marchessault; Paul A Offit; Thomas P Monath
Journal:  MMWR Recomm Rep       Date:  2002-11-08

5.  An inactivated cell-culture vaccine against yellow fever.

Authors:  Thomas P Monath; Elizabeth Fowler; Casey T Johnson; John Balser; Merribeth J Morin; Maggie Sisti; Dennis W Trent
Journal:  N Engl J Med       Date:  2011-04-07       Impact factor: 91.245

Review 6.  Pathogenesis and pathophysiology of yellow fever.

Authors:  Thomas P Monath; Alan D Barrett
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

7.  Longitudinal myelitis associated with yellow fever vaccination.

Authors:  M Chaves; P Riccio; L Patrucco; J I Rojas; E Cristiano
Journal:  J Neurovirol       Date:  2009-07       Impact factor: 2.643

  7 in total
  2 in total

Review 1.  Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature.

Authors:  Erum Khan; Ashish K Shrestha; Mark A Colantonio; Richard N Liberio; Shitiz Sriwastava
Journal:  J Neurol       Date:  2021-09-05       Impact factor: 6.682

Review 2.  Disease Resurgence, Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine?

Authors:  Kay M Tomashek; Mark Challberg; Seema U Nayak; Helen F Schiltz
Journal:  Vaccines (Basel)       Date:  2019-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.